DE69933856D1 - Verwendung von ribozymen zur bestimmung der funktion von genen - Google Patents

Verwendung von ribozymen zur bestimmung der funktion von genen

Info

Publication number
DE69933856D1
DE69933856D1 DE69933856T DE69933856T DE69933856D1 DE 69933856 D1 DE69933856 D1 DE 69933856D1 DE 69933856 T DE69933856 T DE 69933856T DE 69933856 T DE69933856 T DE 69933856T DE 69933856 D1 DE69933856 D1 DE 69933856D1
Authority
DE
Germany
Prior art keywords
nucleic acid
target nucleic
phenotype
expression
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69933856T
Other languages
English (en)
Inventor
G Keck
G Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69933856D1 publication Critical patent/DE69933856D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69933856T 1998-02-13 1999-02-12 Verwendung von ribozymen zur bestimmung der funktion von genen Expired - Lifetime DE69933856D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2399298A 1998-02-13 1998-02-13
PCT/US1999/003166 WO1999041371A1 (en) 1998-02-13 1999-02-12 Use of ribozymes for functionating genes

Publications (1)

Publication Number Publication Date
DE69933856D1 true DE69933856D1 (de) 2006-12-14

Family

ID=21818282

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69933856T Expired - Lifetime DE69933856D1 (de) 1998-02-13 1999-02-12 Verwendung von ribozymen zur bestimmung der funktion von genen

Country Status (7)

Country Link
US (2) US6803194B1 (de)
EP (1) EP1053317B1 (de)
AT (1) ATE344322T1 (de)
AU (1) AU2678999A (de)
CA (1) CA2319112C (de)
DE (1) DE69933856D1 (de)
WO (1) WO1999041371A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
EP0781331B1 (de) 1994-08-20 2008-09-03 Gendaq Limited Verbesserung in bezug auf bindungsproteine bei der erkennung von dna
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US6410248B1 (en) 1998-01-30 2002-06-25 Massachusetts Institute Of Technology General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
AU746454B2 (en) 1998-03-02 2002-05-02 Massachusetts Institute Of Technology Poly zinc finger proteins with improved linkers
US6977154B1 (en) 1998-03-17 2005-12-20 Gendaq Limited Nucleic acid binding proteins
US7070934B2 (en) 1999-01-12 2006-07-04 Sangamo Biosciences, Inc. Ligand-controlled regulation of endogenous gene expression
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US20030104526A1 (en) 1999-03-24 2003-06-05 Qiang Liu Position dependent recognition of GNN nucleotide triplets by zinc fingers
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
AU776576B2 (en) * 1999-12-06 2004-09-16 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
AU2693501A (en) 2000-01-24 2001-07-31 Gendaq Ltd Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
WO2002046412A2 (en) 2000-12-07 2002-06-13 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
WO2002057294A2 (en) 2001-01-22 2002-07-25 Sangamo Biosciences, Inc. Zinc finger proteins for dna binding and gene regulation in plants
US20040110177A1 (en) * 2001-02-02 2004-06-10 Axel Ullrich Method for identifying functional nucleic acids
US7262054B2 (en) 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
GB0202543D0 (en) * 2002-02-04 2002-03-20 Isis Innovation Model systems
US7157274B2 (en) * 2002-06-24 2007-01-02 Cytonome, Inc. Method and apparatus for sorting particles
US9943847B2 (en) 2002-04-17 2018-04-17 Cytonome/St, Llc Microfluidic system including a bubble valve for regulating fluid flow through a microchannel
US20070065808A1 (en) * 2002-04-17 2007-03-22 Cytonome, Inc. Method and apparatus for sorting particles
US6976590B2 (en) * 2002-06-24 2005-12-20 Cytonome, Inc. Method and apparatus for sorting particles
US6808075B2 (en) 2002-04-17 2004-10-26 Cytonome, Inc. Method and apparatus for sorting particles
ATE419865T1 (de) * 2002-08-14 2009-01-15 Silence Therapeutics Ag Verwendung von protein-kinase-n-beta
US7361635B2 (en) 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes
WO2004072261A2 (en) * 2003-02-11 2004-08-26 Immusol Incorporated Sirna libraries optimized for predetermined protein families
FR2852021B1 (fr) * 2003-03-04 2007-12-07 Methodes et outils pour le criblage d'arn actifs in cellulo
US7510856B2 (en) * 2003-03-25 2009-03-31 Hyman Edward D Method for plasmid preparation by conversion of open circular plasmid to supercoiled plasmid
US20050084938A1 (en) * 2003-03-25 2005-04-21 Hyman Edward D. Method for plasmid preparation by conversion of open circular plasmid to supercoiled plasmid
US9260693B2 (en) 2004-12-03 2016-02-16 Cytonome/St, Llc Actuation of parallel microfluidic arrays

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US94324A (en) * 1869-08-31 Samuel lawrence
US5504200A (en) 1983-04-15 1996-04-02 Mycogen Plant Science, Inc. Plant gene expression
US5190931A (en) 1983-10-20 1993-03-02 The Research Foundation Of State University Of New York Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
US5272065A (en) 1983-10-20 1993-12-21 Research Foundation Of State University Of New York Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
GB8626879D0 (en) 1986-11-11 1986-12-10 Ici Plc Dna
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US5037746A (en) 1986-12-03 1991-08-06 University Patents, Inc. RNA ribozyme polymerases, and methods
US5866701A (en) 1988-09-20 1999-02-02 The Board Of Regents For Northern Illinois University Of Dekalb HIV targeted hairpin ribozymes
US5217879A (en) 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
US5364678A (en) * 1989-10-17 1994-11-15 Malden Mills Industries, Inc. Windproof and water resistant composite fabric with barrier layer
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5180818A (en) 1990-03-21 1993-01-19 The University Of Colorado Foundation, Inc. Site specific cleavage of single-stranded dna
JPH06502988A (ja) 1990-07-26 1994-04-07 ファウンデーション・フォー・リサーチ・アンド・テクノロジー　―　ヘラス（エフオー．アール．ティー．エイチ．）インスティテュート・オブ・モレキュラー・バイオロジー・アンド・バイオテクノロジー ポータブルリボザイムカセット、それを含有するｄｎａ配列、これらｄｎａ配列によりコードされるリボザイム、およびこれらリボザイムを含有する組成物
CZ49693A3 (en) 1990-09-24 1994-02-16 Gen Hospital Corp Method for testing of a compound capability to inhibit onco-protein activity
US5217889A (en) 1990-10-19 1993-06-08 Roninson Igor B Methods and applications for efficient genetic suppressor elements
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5496698A (en) * 1992-08-26 1996-03-05 Ribozyme Pharmaceuticals, Inc. Method of isolating ribozyme targets
EP1195442A3 (de) 1992-12-04 2002-07-31 Innovir Laboratories, Inc. Signalverstärkung mittels Ribozyme im Diagnoseverfahren
EP0694068B1 (de) 1993-03-09 2003-02-12 The Board Of Trustees Of The University Of Illinois Mit chemotherapeutische zusammensetzungenassoziierten genetischen suppressor-elementen
CA2163129A1 (en) 1993-05-17 1994-11-24 Flossie Wong-Staal Ribozyme gene therapy for hiv infection and aids
US6133028A (en) 1993-05-28 2000-10-17 Transgene S.A. Defective adenoviruses and corresponding complementation lines
FR2705686B1 (fr) 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
US5834256A (en) 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
US5589362A (en) 1993-06-14 1996-12-31 Basf Aktiengesellschaft Tetracycline regulated transcriptional modulators with altered DNA binding specificities
US6514745B1 (en) * 1993-07-19 2003-02-04 The Regents Of The University Of California Oncoprotein protein kinase
US5631236A (en) 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
US5667969A (en) 1993-11-12 1997-09-16 University Research Corporation Alteration of sequence of a deleterious target molecule by ribozyme catalyzed trans-splicing
AU1257495A (en) 1993-11-18 1995-06-06 Chiron Corporation Compositions and methods for utilizing conditionally lethal genes
FR2712603B1 (fr) 1993-11-18 1996-02-09 Centre Nat Rech Scient Virus recombinants, préparation et utilisation en thérapie génique.
FR2712602B1 (fr) 1993-11-18 1996-02-09 Centre Nat Rech Scient Virus recombinants, préparation et utilisation en thérapie génique.
US6130092A (en) 1994-07-04 2000-10-10 Max-Planck Gesellschaft Zur Forderung Der Wissenschaften E.V. Ribozyme gene library and method for making
DE4424762C1 (de) * 1994-07-04 1995-07-27 Max Planck Gesellschaft Ribozym-Bibliothek, ihre Herstellung und ihre Verwendung
DE69531387T2 (de) 1994-08-16 2004-04-22 Crucell Holland B.V. Von Adenovirus abgeleitete rekombinante Vektoren, für Gentherapie
FR2723697B1 (fr) 1994-08-17 1996-09-20 Rhone Poulenc Rorer Sa Methode de traitement de la restenose par la therapie genique
US5599706A (en) 1994-09-23 1997-02-04 Stinchcomb; Dan T. Ribozymes targeted to apo(a) mRNA
JPH11505724A (ja) 1995-06-02 1999-05-25 エム・アンド・イー・バイオテク・エー／エス 生物活性ペプチド及び核酸の同定方法
KR100449181B1 (ko) 1995-06-15 2005-01-24 크루셀 홀란드 비.브이. 유전자요법에사용할수있는사람의재조합아데노바이러스패키징시스템
US5679523A (en) 1995-11-16 1997-10-21 The Board Of Trustees Of The Leland Stanford Junior University Method for concurrent disruption of expression of multiple alleles of mammalian genes
AU1707497A (en) 1996-01-23 1997-08-20 Rigel Pharmaceuticals, Inc. Methods for screening for transdominant intracellular effector peptides and rna molecules
US6255071B1 (en) 1996-09-20 2001-07-03 Cold Spring Harbor Laboratory Mammalian viral vectors and their uses
US6025192A (en) 1996-09-20 2000-02-15 Cold Spring Harbor Laboratory Modified retroviral vectors
GB2319773B (en) 1996-11-30 2000-08-23 Aea Technology Plc Antisense vector
US6605429B1 (en) * 1997-01-23 2003-08-12 Immusol, Incorporated Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries
JP2001525667A (ja) 1997-05-09 2001-12-11 リボザイム・ファーマシューティカルズ・インコーポレーテッド Ｃ−ｒａｆの発現レベルに関係した疾患または状態の酵素核酸処置
US6183959B1 (en) * 1997-07-03 2001-02-06 Ribozyme Pharmaceuticals, Inc. Method for target site selection and discovery
US6391311B1 (en) 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
DK2016951T3 (da) 1998-03-17 2012-09-24 Genentech Inc VEGF- og BMP1-homologe polypeptider
WO2002048403A2 (en) 2000-12-11 2002-06-20 Hk Pharmaceuticals, Inc. Multiplexed protein expression and activity assay

Also Published As

Publication number Publication date
CA2319112A1 (en) 1999-08-19
CA2319112C (en) 2003-10-28
EP1053317A1 (de) 2000-11-22
AU2678999A (en) 1999-08-30
ATE344322T1 (de) 2006-11-15
WO1999041371A1 (en) 1999-08-19
US6803194B1 (en) 2004-10-12
US20030087288A1 (en) 2003-05-08
EP1053317B1 (de) 2006-11-02

Similar Documents

Publication Publication Date Title
DE69933856D1 (de) Verwendung von ribozymen zur bestimmung der funktion von genen
Cho et al. Parallel analysis of genetic selections using whole genome oligonucleotide arrays
Martinez et al. miR-29 and miR-30 regulate B-Myb expression during cellular senescence
Kumar et al. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts
Akazawa et al. A mammalian helix-loop-helix factor structurally related to the product of Drosophila proneural gene atonal is a positive transcriptional regulator expressed in the developing nervous system
US9458509B2 (en) Multiple input biologic classifier circuits for cells
US20200202981A1 (en) Methods for designing guide sequences for guided nucleases
Berns et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway
Hiller et al. Pre-mRNA secondary structures influence exon recognition
CN109415724A (zh) 日志记录的分子事件的时机
CA2545675A1 (en) Rnai potency prediction method
Xu et al. MicroRNA-mediated target mRNA cleavage and 3′-uridylation in human cells
Tompitak et al. Genomes of multicellular organisms have evolved to attract nucleosomes to promoter regions
Zheng et al. A broadly applicable high-throughput screening strategy identifies new regulators of Dlg4 (Psd-95) alternative splicing
JPH10507647A (ja) 薬剤のスクリーニング法
Tsai et al. Origin replication complex binding, nucleosome depletion patterns, and a primary sequence motif can predict origins of replication in a genome with epigenetic centromeres
Kawasaki et al. βFTZ‐F1 dependent and independent activation of Edg78E, a pupal cuticle gene, during the early metamorphic period in Drosophila melanogaster
Karpova et al. Dual utilization of an acceptor/donor splice site governs the alternative splicing of the IRF-3 gene
Donato et al. Genome-wide hierarchy of replication origin usage in Saccharomyces cerevisiae
Suzuki et al. Two intrinsic timing mechanisms set start and end times for dendritic arborization of a nociceptive neuron
Kiss-Toth et al. A novel mammalian expression screen exploiting green fluorescent protein-based transcription detection in single cells
EP2176409B1 (de) Nukleinsäurekonstruktsysteme mit fähigkeit zur diagnose oder behandlung eines zellzustands
Kouhpayeh et al. Development of α4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis
Schneider et al. The virus–host interactome: Knowing the players to understand the game
Hurst et al. Identification of a Compound Origin of Replication at theHMR-E Locus in Saccharomyces cerevisiae

Legal Events

Date Code Title Description
8332 No legal effect for de